Shares of Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) shot up 47.4% on Saturday . The stock traded as high as C$0.14 and last traded at C$0.14. 1,312,210 shares were traded during trading, an increase of 427% from the average session volume of 249,010 shares. The stock had previously closed at C$0.10.
Voyageur Pharmaceuticals Price Performance
The stock has a market cap of C$19.53 million, a PE ratio of -14.00 and a beta of 0.32. The stock’s fifty day moving average is C$0.08 and its 200-day moving average is C$0.06. The company has a debt-to-equity ratio of 3.21, a current ratio of 0.17 and a quick ratio of 0.84.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Featured Stories
- Five stocks we like better than Voyageur Pharmaceuticals
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- ServiceTitan Made Waves in Its IPO, But Is the Stock a Buy?
- What Are Some of the Best Large-Cap Stocks to Buy?
- Netflix: Is This the Perfect Time to Buy a Streaming Powerhouse?
- About the Markup Calculator
- Goldman Sachs Unveils 3 Massive Opportunities for 2025 Investors
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
